Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Alicja Urbaniak

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
10
2023
1186
2.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2022
92
1.930
Why?
Pyrans
5
2021
22
1.890
Why?
Antineoplastic Agents, Phytogenic
3
2021
70
1.420
Why?
Colchicine
5
2021
29
1.380
Why?
Pharmacogenetics
1
2023
52
0.890
Why?
Polyporaceae
1
2023
3
0.880
Why?
Mitosis
4
2022
93
0.850
Why?
Cell Line, Tumor
10
2023
1416
0.840
Why?
Breast Neoplasms
3
2021
1179
0.810
Why?
Induced Pluripotent Stem Cells
1
2022
42
0.800
Why?
Cell Proliferation
9
2023
1013
0.770
Why?
Glioblastoma
1
2022
93
0.740
Why?
Esters
2
2018
22
0.730
Why?
Antibiotics, Antineoplastic
1
2021
81
0.730
Why?
Paclitaxel
1
2020
84
0.720
Why?
Neoplastic Stem Cells
1
2021
103
0.710
Why?
Melanoma
1
2023
290
0.710
Why?
Carbamates
1
2020
17
0.710
Why?
Antioxidants
2
2019
241
0.690
Why?
Drug Screening Assays, Antitumor
7
2021
140
0.670
Why?
Carcinoma, Ductal, Breast
1
2020
90
0.660
Why?
Brain Neoplasms
1
2022
288
0.640
Why?
Lythraceae
1
2018
2
0.640
Why?
Plant Extracts
1
2020
171
0.600
Why?
MCF-7 Cells
4
2021
69
0.590
Why?
Iron
1
2018
122
0.580
Why?
Stilbenes
1
2017
56
0.560
Why?
Exercise
1
2018
503
0.470
Why?
Apoptosis
5
2023
1112
0.460
Why?
Cell Survival
6
2021
602
0.430
Why?
Drug Discovery
2
2023
88
0.400
Why?
Vincristine
2
2022
88
0.380
Why?
Humans
19
2023
50208
0.370
Why?
Amides
3
2020
39
0.370
Why?
Monensin
2
2022
12
0.370
Why?
Cell Death
2
2020
182
0.310
Why?
Athletes
2
2019
102
0.310
Why?
Molecular Docking Simulation
4
2021
75
0.310
Why?
Tubulin Modulators
4
2020
31
0.290
Why?
Double-Blind Method
2
2019
688
0.290
Why?
Gonadotrophs
1
2023
21
0.220
Why?
Tamoxifen
1
2023
60
0.220
Why?
Mycelium
1
2023
3
0.220
Why?
Trametes
1
2023
4
0.220
Why?
Structure-Activity Relationship
3
2021
401
0.210
Why?
Dose-Response Relationship, Drug
4
2021
1378
0.210
Why?
Microtubules
2
2022
45
0.210
Why?
Organoids
1
2022
40
0.200
Why?
Benzoxazines
1
2021
18
0.200
Why?
Sarcoma, Ewing
1
2021
27
0.190
Why?
Morpholines
1
2021
70
0.190
Why?
Receptor, Cannabinoid, CB2
1
2021
58
0.190
Why?
Tissue Culture Techniques
1
2020
40
0.190
Why?
Naphthalenes
1
2021
121
0.180
Why?
Cell Division
1
2021
295
0.180
Why?
Tumor Microenvironment
1
2022
233
0.180
Why?
Molecular Structure
2
2021
296
0.180
Why?
Colchicum
1
2020
4
0.180
Why?
Receptor, Cannabinoid, CB1
1
2021
125
0.180
Why?
Cell Movement
1
2021
249
0.180
Why?
Inhibitory Concentration 50
1
2020
75
0.180
Why?
Cannabinoids
1
2021
105
0.170
Why?
Receptors, Estrogen
1
2020
131
0.170
Why?
G1 Phase
1
2018
14
0.160
Why?
Urethane
1
2018
6
0.160
Why?
Ergometry
1
2018
4
0.160
Why?
Fruit
1
2019
112
0.160
Why?
Poly(ADP-ribose) Polymerases
1
2018
30
0.150
Why?
DNA Fragmentation
1
2018
55
0.150
Why?
Aniline Compounds
1
2018
43
0.150
Why?
G1 Phase Cell Cycle Checkpoints
1
2017
18
0.150
Why?
Neoplasms
4
2020
1249
0.140
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
129
0.140
Why?
Interleukin-6
1
2018
265
0.140
Why?
Sulfonamides
1
2018
128
0.140
Why?
Female
4
2021
26635
0.140
Why?
Randomized Controlled Trials as Topic
1
2019
550
0.140
Why?
Tumor Suppressor Protein p53
1
2018
203
0.140
Why?
Dietary Supplements
1
2019
434
0.130
Why?
Drug Design
3
2020
121
0.120
Why?
Time Factors
1
2020
2922
0.120
Why?
Muscle, Skeletal
1
2019
765
0.110
Why?
Halogenation
2
2020
6
0.090
Why?
Cell Cycle
2
2022
232
0.080
Why?
Tubulin
2
2019
23
0.080
Why?
Young Adult
1
2018
3981
0.080
Why?
Cells, Cultured
2
2021
1581
0.070
Why?
Adult
1
2022
13324
0.070
Why?
Middle Aged
1
2020
12206
0.060
Why?
Follicle Stimulating Hormone
1
2023
43
0.060
Why?
bcl-2-Associated X Protein
1
2022
56
0.050
Why?
Caspase 3
1
2022
97
0.050
Why?
Cytotoxins
1
2021
16
0.050
Why?
Carrier Proteins
1
2023
306
0.050
Why?
Mice
2
2023
5759
0.050
Why?
Binding, Competitive
1
2021
94
0.050
Why?
Enzyme Activation
1
2022
275
0.050
Why?
Protein Biosynthesis
1
2023
254
0.050
Why?
Ligands
1
2021
205
0.050
Why?
Mice, Inbred BALB C
1
2021
305
0.040
Why?
RNA, Messenger
1
2023
1108
0.040
Why?
Molecular Conformation
1
2019
67
0.040
Why?
Male
1
2018
25399
0.040
Why?
HeLa Cells
1
2018
260
0.040
Why?
Tumor Cells, Cultured
1
2018
468
0.040
Why?
Models, Molecular
1
2018
341
0.040
Why?
Animals
2
2023
13246
0.040
Why?
Aged
1
2018
9405
0.020
Why?
Urbaniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description